Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Confidential contracting

Axelar appoints Carl Harald Janson as CEO

Takes control as company prepares to take novel cancer drug to proof-of-concept

- PMLiVE

Gene therapy: the promise comes closer

After decades of development and a trail of failed clinical trials, gene therapy is finally emerging as a worthwhile approach for treating a range of acquired and inherited diseases

Kane & Finkel appoints John Flaherty as European director

John Flaherty has been appointed to the role of European director at Kane & Finkel Healthcare Communications

Virgo Health takes up new apprenticeship scheme

The programme aims to provide a practical alternative to university education

- PMLiVE

Kane & Finkel announces new European director

John Flaherty will handle pan-European clients for the healthcare comms agency

- PMLiVE

GSK discontinues development of Anacor antibiotic

Patients developed resistance to compound during trial

- PMLiVE

AZ pays $273m for Ardelyx renal disease drug

Phase II candidate could tackle fluid overload in kidney and heart disorders

- PMLiVE

Takeda pays $60m for vaccine company LigoCyte

Gains first-in-class norovirus candidate and new vaccine platform

- PMLiVE

Massive crackdown on online pharmacies nets fake drugs

Global agencies shut down 18,000 websites and seize medicines worth $10.5m

- PMLiVE

Less than half of UK healthcare professionals use mobile apps for work

Secondary care use higher than in primary care, according to Cegedim Strategic Data study

- PMLiVE

Louise Tamblin returns to Kantar Health as group director

Moves from Strata Research

Shionogi: an expanding commercial focus

PMLiVE’s new emerging companies series starts with a Japanese firm that’s increasing its European footprint

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links